Journal
NEUROHOSPITALIST
Volume 5, Issue 3, Pages 133-141Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1941874415587680
Keywords
stroke; cerebrovascular disorders; intracranial hemorrhages; neurohospitalist; clinical specialty
Categories
Ask authors/readers for more resources
Intravenous recombinant tissue plasminogen activator was first approved for the treatment of acute ischemic stroke in the United States in 1996. Thrombolytic therapy has been proven to be effective in acute ischemic stroke treatment and shown to improve long-term functional outcomes. Its use is associated with an increased risk of symptomatic intracerebral hemorrhage as well as orolingual angioedema. Our goal is to outline the management strategies for these postthrombolysis complications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available